Ortenau Klinikum

Research site

Germany Klostenstrasse 19, 77933 Lahr, Germany

1 trial recruiting
Acute myeloid leukaemia · Adenocarcinoma gastric · Gastrooesophageal cancer
Adult patients

About Specializations

Ortenau Klinikum in Lahr, Germany specialises in clinical trials of conditions such as Acute myeloid leukaemia, Adenocarcinoma gastric, Gastrooesophageal cancer, Oesophageal adenocarcinoma, and other specialisations. This site conducts important research.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location

Klostenstrasse 1977933 LahrGermany

Open in maps ↗

Recruiting now: 1 trial
Conditions studied: 4

More sites in Lahr Germany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Quick filters

3 clinical trials

Acute myeloid leukaemia

Recruiting

Study on Decitabine, Venetoclax, and Tretinoin for Patients with Acute Myeloid Leukemia Who Cannot Have Induction Chemotherapy

Registered drug

Study on Decitabine, Venetoclax, and Tretinoin for Patients with Acute Myeloid Leukemia Who Cannot Have Induction Chemotherapy

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Placebo
Sponsor:Medical Center - University Of Freiburg

Contact Research Centre

Gastrooesophageal cancer

Not recruiting

Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Registered drugNo placebo

Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Institut fuer Klinische Krebsforschung IKF GmbH

Contact Research Centre

Adenocarcinoma gastric+1

Not recruiting

Study Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy

Registered drugNo placebo

Study Comparing Ramucirumab with Irinotecan, Leucovorin, and 5-FU or Paclitaxel for Patients with Advanced Stomach or Gastroesophageal Cancer After Previous Chemotherapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Calcium Folinate
Sponsor:Institut fuer Klinische Krebsforschung IKF GmbH

Contact Research Centre

Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites